HSIC
59
2
RCL
88
3
PLD
46
6
KEY
57
-10
FSLR
66
-6
HAL
43
2
CMS
57
3
CME
61
2
K
56
3
COST
50
2
CA
1
-9
KMX
53
4
CMA
64
2
L
55
9
BDX
32
2
BRK.B
36
3
DE
69
4
EMC
70
-3
AIG
62
2
ZBH
51
-2
HSIC
59
2
RCL
88
3
PLD
46
6
KEY
57
-10
FSLR
66
-6
HAL
43
2
CMS
57
3
CME
61
2
K
56
3
COST
50
2
CA
1
-9
KMX
53
4
CMA
64
2
L
55
9
BDX
32
2
BRK.B
36
3
DE
69
4
EMC
70
-3
AIG
62
2
ZBH
51
-2
Financhill
Back

Collegium Pharmaceutical Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
47

COLL
Collegium Pharmaceutical

Last Price:
$30.22
Seasonality Move:
-6.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Collegium Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Collegium Pharmaceutical has on average historically risen by 21.4% based on the past 9 years of stock performance.
  • Collegium Pharmaceutical has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Collegium Pharmaceutical Stock Undervalued?
    The current Collegium Pharmaceutical [COLL] share price is $30.23. The Score for COLL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Collegium Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Collegium Pharmaceutical has on average historically risen by 21.4% based on the past 9 years of stock performance.

Collegium Pharmaceutical Stock Rating

Sell
47
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical overpriced?

  • Collegium Pharmaceutical has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Collegium Pharmaceutical Stock Price History

Is COLL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
collegiumpharma.com

52-Week Data

52-Week High:
42.29
52-Week Low:
23.23

Prediction Charts

Market Cap:
971.7M
Price in USD:
30.23
Volume:
430.9K
Beta:
0.82

Technical Analysis

SMA50:
28.32
SMA100:
29.49
SMA200:
32.31
52-Wk Change:
-10.22%

Stock Predictions

  • Is Collegium Pharmaceutical stock public?
    Yes, Collegium Pharmaceutical is a publicly traded company.
  • What is the Collegium Pharmaceutical stock quote today?
    The Collegium Pharmaceutical stock price is 30.23 USD today.
  • How to buy Collegium Pharmaceutical stock online?
    You can buy Collegium Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 26.78 27.60 27.70 26.68
Apr-30 27.23 27.00 27.54 26.93
May-1 26.71 27.06 27.10 26.16
May-2 27.41 27.65 28.19 27.01
May-5 27.56 27.78 28.19 27.52
May-6 27.77 27.03 27.80 26.78
May-7 27.18 27.05 27.34 26.72
May-8 27.08 27.27 27.97 26.81
May-9 29.66 28.89 29.66 27.84
May-12 29.89 29.56 30.46 29.53
May-13 29.48 29.80 30.13 29.19
May-14 29.73 29.07 30.17 28.81
May-15 29.33 29.34 29.80 29.19
May-16 29.25 30.23 30.53 29.19

Collegium Pharmaceutical Earnings

Collegium Pharmaceutical Earnings Report: Per Share Collegium Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Collegium Pharmaceutical Forecast Revenue Growth

Collegium Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Collegium Pharmaceutical and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.36 per share, an increase this year of $1.44 per share, and an increase next year of $0.12 per share.

* Collegium Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.